‘Balanced’ guidance on isotretinoin welcomed as MHRA launches survey

The Commission on Human Medicines (CHM) has endorsed changes to guidance for prescribing acne medication isotretinoin (Roaccutane; Cheplapharm or Reticutan; Ennogen Healthcare), for which some patients have reported mental health and sexual…